Back to Search Start Over

Flow cytometric analysis of myelodysplasia: Pre-analytical and technical issues-Recommendations from the European LeukemiaNet.

Authors :
Velden, V.H. van der
Preijers, F.W.
Johansson, U.
Westers, Theresia M.
Dunlop, A.
Porwit, A.
Béné, M.C.
Valent, P.
Marvelde, J. Te
Wagner-Ballon, O.
Oelschlaegel, U.
Saft, L.
Kordasti, S.
Ireland, R.
Cremers, E.
Alhan, C.
Duetz, C.
Hobo, W.A.
Chapuis, N.
Fontenay, M.
Bettelheim, P.
Eidenshink-Brodersen, L.
Font, P.
Loken, M.R.
Matarraz, S.
Ogata, K.
Orfao, A.
Psarra, K.
Subirá, D.
Wells, D.A.
Porta, M.G. Della
Burbury, K.
Bellos, F.
Weiß, E.
Kern, W.
Loosdrecht, A. van de
Velden, V.H. van der
Preijers, F.W.
Johansson, U.
Westers, Theresia M.
Dunlop, A.
Porwit, A.
Béné, M.C.
Valent, P.
Marvelde, J. Te
Wagner-Ballon, O.
Oelschlaegel, U.
Saft, L.
Kordasti, S.
Ireland, R.
Cremers, E.
Alhan, C.
Duetz, C.
Hobo, W.A.
Chapuis, N.
Fontenay, M.
Bettelheim, P.
Eidenshink-Brodersen, L.
Font, P.
Loken, M.R.
Matarraz, S.
Ogata, K.
Orfao, A.
Psarra, K.
Subirá, D.
Wells, D.A.
Porta, M.G. Della
Burbury, K.
Bellos, F.
Weiß, E.
Kern, W.
Loosdrecht, A. van de
Source :
Cytometry. Part B-Clinical Cytometry; 15; 26; 1552-4949; 1; 104; ~Cytometry. Part B-Clinical Cytometry~15~26~~~1552-4949~1~104~~
Publication Year :
2023

Abstract

01 januari 2023<br />Item does not contain fulltext<br />BACKGROUND: Flow cytometry (FCM) aids the diagnosis and prognostic stratification of patients with suspected or confirmed myelodysplastic syndrome (MDS). Over the past few years, significant progress has been made in the FCM field concerning technical issues (including software and hardware) and pre-analytical procedures. METHODS: Recommendations are made based on the data and expert discussions generated from 13 yearly meetings of the European LeukemiaNet international MDS Flow working group. RESULTS: We report here on the experiences and recommendations concerning (1) the optimal methods of sample processing and handling, (2) antibody panels and fluorochromes, and (3) current hardware technologies. CONCLUSIONS: These recommendations will support and facilitate the appropriate application of FCM assays in the diagnostic workup of MDS patients. Further standardization and harmonization will be required to integrate FCM in MDS diagnostic evaluations in daily practice.

Details

Database :
OAIster
Journal :
Cytometry. Part B-Clinical Cytometry; 15; 26; 1552-4949; 1; 104; ~Cytometry. Part B-Clinical Cytometry~15~26~~~1552-4949~1~104~~
Publication Type :
Electronic Resource
Accession number :
edsoai.on1374052490
Document Type :
Electronic Resource